BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Connery K, Tippett M, Delhey LM, Rose S, Slattery JC, Kahler SG, Hahn J, Kruger U, Cunningham MW, Shimasaki C, Frye RE. Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism. Transl Psychiatry. 2018;8:148. [PMID: 30097568 DOI: 10.1038/s41398-018-0214-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Frye RE, Lane A, Worner A, Werner BA, McCarty PJ, Scheck AC, Collins HL, Adelman SJ, Quadros EV, Rossignol DA. The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment. J Pers Med 2022;12. [PMID: 36556254 DOI: 10.3390/jpm12122033] [Reference Citation Analysis]
2 Sherman HT, Liu K, Kwong K, Chan ST, Li AC, Kong XJ. Carbon monoxide (CO) correlates with symptom severity, autoimmunity, and responses to probiotics treatment in a cohort of children with autism spectrum disorder (ASD): a post-hoc analysis of a randomized controlled trial. BMC Psychiatry 2022;22:536. [PMID: 35941573 DOI: 10.1186/s12888-022-04151-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jensen AR, Lane AL, Werner BA, McLees SE, Fletcher TS, Frye RE. Modern Biomarkers for Autism Spectrum Disorder: Future Directions. Mol Diagn Ther 2022. [PMID: 35759118 DOI: 10.1007/s40291-022-00600-7] [Reference Citation Analysis]
4 Karczewski J, Zielińska A, Staszewski R, Eder P, Dobrowolska A, Souto EB. Obesity and the Brain. Int J Mol Sci 2022;23:6145. [PMID: 35682824 DOI: 10.3390/ijms23116145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Frye RE. A Personalized Multidisciplinary Approach to Evaluating and Treating Autism Spectrum Disorder. JPM 2022;12:464. [DOI: 10.3390/jpm12030464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Endres D, Pollak TA, Bechter K, Denzel D, Pitsch K, Nickel K, Runge K, Pankratz B, Klatzmann D, Tamouza R, Mallet L, Leboyer M, Prüss H, Voderholzer U, Cunningham JL, Domschke K, Tebartz van Elst L, Schiele MA; ECNP Network Immuno-NeuroPsychiatry. Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype? Transl Psychiatry 2022;12:5. [PMID: 35013105 DOI: 10.1038/s41398-021-01700-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
7 Baribeau D, Anagnostou E. Novel treatments for autism spectrum disorder based on genomics and systems biology. Pharmacol Ther 2021;:107939. [PMID: 34174273 DOI: 10.1016/j.pharmthera.2021.107939] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
8 Kang J, Jin Y, Liang G, Li X. Accurate assessment of low-function autistic children based on EEG feature fusion. J Clin Neurosci 2021;90:351-8. [PMID: 34275574 DOI: 10.1016/j.jocn.2021.06.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Rossignol DA, Frye RE. A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder. J Pers Med 2021;11:488. [PMID: 34070826 DOI: 10.3390/jpm11060488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
10 Al-Beltagi M. Autism medical comorbidities. World J Clin Pediatr 2021;10:15-28. [PMID: 33972922 DOI: 10.5409/wjcp.v10.i3.15] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
11 Al-Beltagi M. Autism medical comorbidities. World J Clin Pediatr 2021;10:15-28. [PMID: 33972922 DOI: 10.5409/wjcp.v10.i3.15] [Reference Citation Analysis]
12 Balint B, Bhatia KP, Dalmau J. "Antibody of Unknown Significance" (AUS): The Issue of Interpreting Antibody Test Results. Mov Disord 2021;36:1543-7. [PMID: 33955060 DOI: 10.1002/mds.28597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Pilli D, Zou A, Dawes R, Lopez JA, Tea F, Liyanage G, Lee FX, Merheb V, Houston SD, Pillay A, Jones HF, Ramanathan S, Mohammad S, Kelleher AD, Alexander SI, Dale RC, Brilot F. Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders. Clin Transl Immunology 2020;9:e1229. [PMID: 33425355 DOI: 10.1002/cti2.1229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Parkhouse RME, Sciutto E, Hernández M, Cortez MM, Carpio A, Fleury A. Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35–55 in cerebral spinal fluid. Journal of Neuroimmunology 2020;349:577389. [DOI: 10.1016/j.jneuroim.2020.577389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Endres D, Rauer S, Pschibul A, Süß P, Venhoff N, Runge K, Feige B, Denzel D, Nickel K, Schweizer T, Maier S, Egger K, Domschke K, Meyer PT, Prüss H, Tebartz van Elst L. Novel Antineuronal Autoantibodies With Somatodendritic Staining Pattern in a Patient With Autoimmune Psychosis. Front Psychiatry 2020;11:627. [PMID: 32848899 DOI: 10.3389/fpsyt.2020.00627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Pacheva I, Ivanov I. Targeted Biomedical Treatment for Autism Spectrum Disorders. Curr Pharm Des 2019;25:4430-53. [PMID: 31801452 DOI: 10.2174/1381612825666191205091312] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Runge K, Tebartz van Elst L, Maier S, Nickel K, Denzel D, Matysik M, Kuzior H, Robinson T, Blank T, Dersch R, Domschke K, Endres D. Cerebrospinal Fluid Findings of 36 Adult Patients with Autism Spectrum Disorder. Brain Sci 2020;10:E355. [PMID: 32521749 DOI: 10.3390/brainsci10060355] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
18 Dudova I, Horackova K, Hrdlicka M, Balastik M. Can Maternal Autoantibodies Play an Etiological Role in ASD Development? Neuropsychiatr Dis Treat 2020;16:1391-8. [PMID: 32581542 DOI: 10.2147/NDT.S239504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Pape K, Tamouza R, Leboyer M, Zipp F. Immunoneuropsychiatry - novel perspectives on brain disorders. Nat Rev Neurol 2019;15:317-28. [PMID: 30988501 DOI: 10.1038/s41582-019-0174-4] [Cited by in Crossref: 182] [Cited by in F6Publishing: 188] [Article Influence: 60.7] [Reference Citation Analysis]
20 Shimasaki C, Frye RE, Trifiletti R, Cooperstock M, Kaplan G, Melamed I, Greenberg R, Katz A, Fier E, Kem D, Traver D, Dempsey T, Latimer ME, Cross A, Dunn JP, Bentley R, Alvarez K, Reim S, Appleman J. Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms. J Neuroimmunol 2020;339:577138. [PMID: 31884258 DOI: 10.1016/j.jneuroim.2019.577138] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
21 Frye RE, Vassall S, Kaur G, Lewis C, Karim M, Rossignol D. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med 2019;7:792. [PMID: 32042808 DOI: 10.21037/atm.2019.11.53] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
22 Hafizi S, Tabatabaei D, Lai MC. Review of Clinical Studies Targeting Inflammatory Pathways for Individuals With Autism. Front Psychiatry 2019;10:849. [PMID: 31824351 DOI: 10.3389/fpsyt.2019.00849] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
23 Whiteley P, Carr K, Shattock P. Is Autism Inborn And Lifelong For Everyone? Neuropsychiatr Dis Treat 2019;15:2885-91. [PMID: 31632036 DOI: 10.2147/NDT.S221901] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
24 Harville T, Rhodes-Clark B, Bennuri SC, Delhey L, Slattery J, Tippett M, Wynne R, Rose S, Kahler S, Frye RE. Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD). Front Psychiatry 2019;10:612. [PMID: 31572230 DOI: 10.3389/fpsyt.2019.00612] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
25 Bejerot S, Klang A, Hesselmark E. The Cunningham Panel: concerns remain. Transl Psychiatry 2019;9:224. [PMID: 31506420 DOI: 10.1038/s41398-019-0562-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Frye RE, Shimasaki C. Reliability of the Cunningham Panel. Transl Psychiatry 2019;9:129. [PMID: 30962420 DOI: 10.1038/s41398-019-0462-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bejerot S, Hesselmark E. The Cunningham Panel is an unreliable biological measure. Transl Psychiatry 2019;9:49. [PMID: 30705260 DOI: 10.1038/s41398-019-0413-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]